Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Current Deferred Revenue: 2011-2012

Historic Current Deferred Revenue for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Mar 2012 value amounting to $1.6 million.

  • Sonoma Pharmaceuticals' Current Deferred Revenue rose 54.81% to $2.9 million in Q4 2012 from the same period last year, while for Dec 2012 it was $2.9 million, marking a year-over-year increase of 54.81%. This contributed to the annual value of $1.6 million for FY2012, which is 10.45% down from last year.
  • Sonoma Pharmaceuticals' Current Deferred Revenue amounted to $1.6 million in FY2012, which was down 10.45% from $1.8 million recorded in FY2011.
  • Sonoma Pharmaceuticals' Current Deferred Revenue's 5-year high stood at $1.8 million during FY2011, with a 5-year trough of $1.6 million in FY2012.
  • For the 2-year period, Sonoma Pharmaceuticals' Current Deferred Revenue averaged around $1.7 million, with its median value being $1.7 million (2011).
  • Data for Sonoma Pharmaceuticals' Current Deferred Revenue shows a maximum YoY fell of 10.45% (in 2012) over the last 5 years.
  • Yearly analysis of 2 years shows Sonoma Pharmaceuticals' Current Deferred Revenue stood at $1.8 million in 2011, then declined by 10.45% to $1.6 million in 2012.